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Objective: Evaluate the association of Helicobacter pylori infection with anti-parietal cell anti-
bodies (APCA) and anti-intrinsic factor antibodies (AIFA) and their impact on vitamin B12
serum level.
Patients and methods: One hundred patients (M/F: 43/57; age 46.5 ± 17.5 years) who underwent
upper gastrointestinal endoscopy at King Abdullah University Hospital, Irbid, Jordan were
enrolled in the study. The patients were grouped as H. pylori-infected (n = 81) or H. pylori
negative (n = 19) by histopathological examination. Fasting serum vitamin B12 levels, anti-
parietal cell antibodies and anti-intrinsic factor antibodies for patients and controls were
determined.
Results: Anti-parietal cell antibodies and anti-intrinsic factor antibodies were positive in
9.9%  and 18.5% of H. pylori-positive patients respectively. None of the H. pylori negative
subjects had anti-parietal cell antibodies or anti-intrinsic factor antibodies. Serum vita-
min B12 level was lower in the H. pylori-infected patients (275 ± 70.4 pg/mL) than in controls
(322.9  ± 60.7 pg/mL; p < 0.05). H. pylori was positive in 94% of the low-vitamin B12 group
compared with 64.6% of the normal-vitamin B12 group (p < 0.5).
Conclusion: Patients with H. pylori infection are more likely to have anti-parietal cell anti-bodies and anti-intrinsic factor antibodies. There was an association between H. pylori
infection and lower vitamin B12 levels. H. pylori infection might be a signiﬁcant factor in
the  pathogenesis of autoimmune gastritis.
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prevalence of H. pylori infection in northern Jordan is 82%.
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by age, country of origin, and socioeconomic status. The
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Worldwide, H. pylori infection affects 50% of the population.
H. pylori usually causes asymptomatic gastric infection.
Chronic gastritis, peptic ulcer disease, and atrophic gastritis
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Table 1 – Association of APCA and AIFA with H.  pylori
infection.
APCA and AIFA H. pylori status Contingency
coefﬁcients
Positive
n  = 81
Negative
n  = 19
APCA
Positive n = 8 8 0 Phi = 1
Negative n = 73 73 0
AIFA
Positive n = 15 15 0 Phi = 1
Negative n = 66 66 0
level compared to 64.6% of those with normal level (p < 0.5).
AIFA were detected among 50% of those with low vitamin B12
level and in 15.5% of those with normal level (p < 0.5) (Table 2).
Table 2 – Parameters associated with serum levels of
vitamin B12.
Parameters Vitamin B12
Level < 200 pg/mL
n = 16
Vitamin B12
Level > 200 pg/mL
n = 84
p-Value
Age (years) 50.3 ± 23.5 45.8 ± 16.2 0.35
H. pylori (positive) 93.8% 64.6% <0.05
Gastric atrophy 6.3% 2.4% 0.97
AIFA 50% 15.5% <0.05630  b r a z j i n f e c t d 
are recognized consequences of this infection. Although
H. pylori infection causes gastric inﬂammation virtually
in all infected subjects, the majority of infected subjects
remain asymptomatic, while certain subset of patients
develops atrophic gastritis.3 There is growing evidence of the
relationship between low serum vitamin B12 and H. pylori
infection,4,5 suggesting that vitamin B12 deﬁciency, especially
in developing countries, is frequently caused by chronic H.
pylori gastritis.6–8 In fact, high frequency of suboptimal serum
vitamin B12 level has been found in adults in Jordan.9
Antibodies to intrinsic factor (AIFA), which block the bind-
ing of cobalamin to intrinsic factor, have been reported in
31–76% of patients with pernicious anemia.10 Anti-parietal
cell antibodies (APCA) are associated with atrophic gastritis,
and often occur in subjects with gastritis in the absence of
pernicious anemia.11,12
The main objective of this study was to evaluate the asso-
ciation of H. pylori infection with APCA and AIFA, and their
impact on serum vitamin B12 level.
Patients  and  methods
This study was approved by the Institutional Review Board of
Jordan University of Science and Technology and King Abdul-
lah University Hospital (KAUH). The study was prospectively
conducted at King Abdullah University Hospital, Irbid, Jordan
from June 2007 to June 2008. Patients who were referred for
upper gastrointestinal endoscopic examination (UGE) for dys-
peptic complaints were enrolled in this study. All the patients
signed a written consent form. Patients were excluded from
this study if they had any of the following: prior eradication
therapy for H. pylori, history of gastrointestinal bleeding, his-
tory of gastric surgery, vitamin B12 supplementation in the
past three years prior to their enrollment, or pregnancy.
An UGE was performed and at least two biopsy spec-
imens were obtained from the antrum and corpus of the
stomach. The biopsy tissue was prepared with hematoxylin
and eosin, Giemsa staining, and toludine blue to identify H.
pylori. Findings of gastric atrophy and H. pylori were recorded.
Histopathological examination was performed independently
by two experienced pathologists.
Venous blood sample was taken from each patient at the
time of UGE for determination of serum vitamin B12 level,
APCA and AIFA. Serum vitamin B12 level was determined
by using an auto analyzer instrument (Elecseys, USA). Serum
vitamin B12 level less than or equal to 200 pg/mL was consid-
ered low, while serum level above 200 pg/mL was considered
normal.
APCA were determined by indirect ﬂuorescent antibody
tests by using a commercially available kit (The Binding Site
Ltd., UK). AIFA were determined by using a commercially avail-
able kit (AIFA, Organic, Germany) based on enzyme-linked
immune-sorbent assay (ELISA).
Statistical  analysisThe statistical analysis was performed using computerized
Statistical Package for Social Science (SPSS) program for win-
dows, version 15, and EpiCal program. Numeric values wereAPCA, anti-parietal cell antibodies; AIFA, anti-intrinsic factor
antibodies.
expressed as mean values ± SD. p-Values were calculated by
using two-tailed t-test to compare the difference of means
between two groups. The difference was considered statisti-
cally signiﬁcant if the p-value was ≤0.05.
Results
A total of one hundred patients met  the inclusion criteria and
agreed to participate in the study. H. pylori was positive in 81
patients (81%), 57% were male, mean age of 46 years (range
18–90); H. pylori was negative in 19 patients (19%), 58% were
male, mean age of 47 years (range 21–78).
Gastric atrophy was present in 30 (37%) H. pylori-positive
and in none H. pylori-negative patients (p = 0.91). APCA were
present in 8 (9.9%) H. pylori-positive and in none H. pylori-
negative patients (p = 0.34). AIFA were present in 15 (18.5%) H.
pylori-positive and in none H. pylori-negative patients (p = 0.09).
APCA and AIFA were only present in H. pylori-infected patients.
Using phi coefﬁcient to measure of the degree of association,
there was a strong association between both APCA and AIFA
and the presence of H. pylori infection (Phi = 1) (Table 1).
Serum vitamin B12 level was 257.6 ± 79.4 pg/mL in H. pylori
positive and 322.9 ± 60.7 pg/mL in H. pylori-negative patients
(p < 0.05). Low vitamin B12 was found in 16 patients (16%). H.
pylori was positive in 94% among those with low vitamin B12APCA 12.5% 7.2% 0.83
APCA, anti-parietal cell antibodies; AIFA, anti-intrinsic factor
antibodies.
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iscussion
he present study disclosed certain association between AIFA
nd H. pylori infection. Additionally, results from this study
howed increased APCA positivity among H. pylori-infected
atients, but not among H. pylori-negative patients. The pres-
nce of APCA might be a host factor that contribute to the
nal outcome of chronic H. pylori infection.13 These results
re consistent with other studies.14 Lo et al.,15 in their preva-
ence study of APCA and anti-H. pylori antibodies (AHPA) in
atients with gastric adenocarcinoma, found that the preva-
ence rates of APCA and AHPA were 70% and 53%, respectively,
hile the prevalence was much lower in controls. The authors
oncluded that APCA and AHPA can predict atrophic gastritis
nd, consequently, gastric cancer. In our study, the associa-
ion was not statistically signiﬁcant, possibly due to the small
ample size, thus reducing the statistical power of the test.
A controlled Italian study16 of asymptomatic subjects with
PCA and patients with pernicious anemia found atrophic
astritis on histopathological examination in 18% of asymp-
omatic APCA subjects, in 75% of patients with pernicious
nemia, and only in 3% of controls. In this study, H. pylori was
ound in 61% of patients without gastric atrophy, while only
9% of patients with atrophy were positive for H. pylori. This
esult could be explained by the reduction of H. pylori infection
s acid secretion decreases. The authors of this Italian study
oncluded that the frequent detection of H. pylori in subjects
ith early autoimmune gastritis suggests that H. pylori could
ave a role in the induction and/or maintenance of autoimmu-
ity at the gastric level. Similar to the above study, we found
ome association between H. pylori infection and markers of
utoimmune gastritis, suggesting that H. pylori infection could
rigger gastric autoimmunity.
Initial data showed no signiﬁcant differences between
ales and females investigated in this study. Therefore, all
ata presented here are for both genders combined.
Our study included 100 patients referred for UGE to inves-
igate symptoms of dyspepsia. Eighty-one patients proved to
ave H. pylori infection by histopathological examination of
astric biopsies. The other 19 patients were found to be H.
ylori negative by histopathological examination. This ﬁnding
s consistent with other studies from Jordan which showed a
revalence rate of H. pylori infection to be around 80%.1
Concerning the presence of AIFA, results from this study
emonstrated higher prevalence in H. pylori-infected patients.
o our knowledge, no previous studies were conducted to
valuate the prevalence of AIFA in H. pylori-infected patients.
oreover, the presence of AIFA was strongly associated with
ower vitamin B12 serum level (p < 0.05).
Comparing serum vitamin B12 levels in patients infected
nd not infected with H. pylori showed a signiﬁcant difference,
ith lower serum vitamin B12 level in the infected group (p-
alue < 0.05).
Patients with low serum vitamin B12 level had high preva-
ence of gastric atrophy and APCA, but this was not statistically
igniﬁcant. AIFA prevalence in patients with low serum level
f vitamin B12 was statistically signiﬁcant (p < 0.05).
In our study we  found a signiﬁcant association between
. pylori infection, AIFA and APCA. It appears that these
13;1 7(6):629–632 631
antibodies are only present in H. pylori-infected patients.
Based on the results of our study, it is arguable that H. pylori
infection could lead to autoimmune gastritis, as reported by
other investigators.17
The limitation of this study is the small sample of con-
trol individuals, because of the very high prevalence of H.
pylori infection in Jordan. This could have led to the lack of
statistically signiﬁcant differences between H. pylori-infected
patients and controls. Another limitation of our study is the
lack of clinical parameters of vitamin B12 deﬁciency.
In conclusion, our study showed a strong association
between H. pylori infection and the presence of antibodies to
gastric parietal cell and to intrinsic factor. AIFA is associated
with low serum level of vitamin B12. Therefore, a putative
relationship between H. pylori infection and gastric autoim-
munity is suggested. However, we  believe that large-scale
age-matched prospective studies are required to establish the
deﬁnite association between APCA, AIFA, H. pylori infection
and B12 deﬁciency.
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